Valuation: Boston Scientific Corporation

Market Cap 64.07B 58.06B 53.7B 48.45B 91.31B 6,041B 94.52B 645B 256B 3,227B 240B 235B 10,243B P/E 2026 *
18x
P/E 2027 * 19.3x
Enterprise Value 74.55B 67.56B 62.49B 56.38B 106B 7,029B 110B 751B 298B 3,755B 280B 274B 11,919B EV / Sales 2026 *
3.56x
EV / Sales 2027 * 3.42x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
12/11 Boston Scientific Corporation Presents at Stifel 2026 Healthcare Conference 2026, Nov-11-2026 08:00 AM
07/11 Boston Scientific Neuromodulation Corporation Announces Nalu Td2 Therapy Disc Recall CI
03/11 Blackstone Life Sciences, Boston Scientific to Co-Fund Heart Pump MT
03/11 Blackstone, Boston Scientific Sign $455 Million Deal to Co-Fund Heart Pump DJ
03/11 Blackstone Life Sciences Announces Collaboration with Boston Scientific Corporation to Co-Fund Development of VITALYST Heart Pump CI
03/11 Boston Scientific Corporation Announces Positive Six-Month Primary Endpoint Results From SIMPLAAFY Randomized Controlled Trial of WATCHMAN FLX Pro Left Atrial Appendage Closure Device CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/TRANSEND/021/STRAIGHT/1RO/130; Material Number: M001195810 CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/027/STRAIGHT/1RO/130; Material Number: M001195410 CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/027/STRAIGHT/1RO/105; Material Number: M001195400 CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/027/BERN/1RO/105; Material Number: M001195430 CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/021/SWAN/1RO/155; Material Number: M001195310 CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/021/SWAN/1RO/105; Material Number: M001195290 CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/021/STRAIGHT/1RO/130; Material Number: M001195210 CI
1 day+0.31%
1 week+3.61%
Current month+5.51%
1 month+2.27%
3 months-14.31%
6 months-16.52%
Current year-53.54%
1 week 43.04
Extreme 43.04
45.82
1 month 39.57
Extreme 39.57
46.97
Current year 39.57
Extreme 39.57
100.9
1 year 39.57
Extreme 39.57
104.62
3 years 39.57
Extreme 39.57
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
4/11/26 Don

Chief Executive Officer

252,241 0.0171%
1/11/26 Exercice

Head of Human Resources

9,614 0.0007%
25/8/26 Buy

Director

2,040 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%+3.61%-57.81%-17.53% 64.07B
+0.08%+0.58%+20.46%+56.98% 259B
+0.36%+1.36%+5.50%+19.08% 163B
+1.25%-1.48%-21.12%+57.92% 152B
+1.40%+5.15%+24.73%+66.26% 60.84B
+0.34%-2.33%-1.94%-7.69% 53.91B
+0.58%-0.37%+18.54%+62.03% 48.78B
-0.13%-0.60%+3.50%+81.60% 48.96B
-0.37%+0.64%+21.41%+83.49% 45.43B
+1.39%+0.63%+12.07%+18.41% 37B
Average +0.50%+0.06%+2.53%+42.06% 93B
Weighted average by Cap. +0.45%+0.49%+3.40%+43.58%

Financials

2026 *2027 *
Net sales 20.97B 19B 17.58B 15.86B 29.88B 1,977B 30.94B 211B 83.72B 1,056B 78.69B 77.02B 3,352B 20.88B 18.92B 17.5B 15.79B 29.75B 1,969B 30.8B 210B 83.36B 1,052B 78.35B 76.69B 3,338B
Net income 3.53B 3.2B 2.96B 2.67B 5.03B 333B 5.21B 35.56B 14.1B 178B 13.25B 12.97B 565B 3.27B 2.96B 2.74B 2.47B 4.66B 308B 4.83B 32.94B 13.06B 165B 12.28B 12.02B 523B
Net Debt 10.48B 9.5B 8.79B 7.93B 14.94B 989B 15.47B 106B 41.86B 528B 39.35B 38.51B 1,676B 7.39B 6.7B 6.19B 5.59B 10.53B 697B 10.9B 74.39B 29.5B 372B 27.73B 27.14B 1,181B
Projected Income Statement - Annual - Boston Scientific Corporation
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
14/11/26 USD 44.36 +0.36% 6,706,678
12/11/26 USD 44.20 -2.06% 11,505,058
11/11/26 USD 45.13 +0.96% 17,786,952
10/11/26 USD 44.70 +1.54% 11,713,596
09/11/26 USD 44.02 +2.97% 16,195,827
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Boston Scientific Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
44.20USD
Average target price
49.60USD
Spread / Average Target
+12.21%